Response to neoadjuvant chemotherapy and the 21-gene breast recurrence score in young women with estrogen receptor-positive early breast cancer.

Tal Sella,Shari Gelber,Philip D. Poorvu,Hee Jeong Kim,Yaileen D Guzman-Arocho,Laura C. Collins,Kathryn J. Ruddy,Rulla M. Tamimi,Jeffrey Peppercorn,Lidia Schapira,Virginia F. Borges,Steven E. Come,Ellen Warner,Craig Snow,Debbie M Jakubowski,Christy A. Russell,Eric P. Winer,Shoshana M. Rosenberg,Ann H. Partridge

Response to neoadjuvant chemotherapy and the 21-gene breast recurrence score in young women with estrogen receptor-positive early breast cancer.

2020

Tal Sella
Shari Gelber
Philip D. Poorvu
Hee Jeong Kim
Yaileen D Guzman-Arocho
Laura C. Collins
Kathryn J. Ruddy
Rulla M. Tamimi
Jeffrey Peppercorn
Lidia Schapira
Virginia F. Borges
Steven E. Come
Ellen Warner
Craig Snow
Debbie M Jakubowski
Christy A. Russell
Eric P. Winer
Shoshana M. Rosenberg
Ann H. Partridge

514Background: The 21-gene Breast Recurrence Score predicts benefit from adjuvant chemotherapy in estrogen receptor positive (ER+), HER-2 negative (-) breast cancer (BC). We aimed to examine whethe...

Keywords:

Oncology
Gene
adjuvant chemotherapy
early breast cancer
recurrence score
Chemotherapy
Breast cancer
Pathology
Estrogen receptor
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations